BD Pharmingen- FITC Active Caspase-3 Apoptosis Kit_BD Pharmingen
- 描述数量/尺寸零件号EntrezGene ID
- FITC Rabbit Anti- Active Caspase-3100 Tests (1 ea)51-68654XN/A
- Cytofix/Cytoperm™ Fixation and Permeabilization Solution (1X)N/A51-6896KCN/A
- Perm/Wash™ Buffer (10X Solution)N/A51-6897KCN/A
参考图片
Flow cytometric analysis of apoptotic and non-apoptotic populations for active caspase-3. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were left untreated (left panel) or treated for 4 hr with camptothecin (right panel) to induce apoptosis. Cells were permeabilized, fixed, and stained for active caspase-3 as described in the accompanying Staining Protocol. Cells were then analyzed by flow cytometry. Untreated cells were primarily negative for the presence of active caspase-3, whereas greater than one third of the treated cells were positive for active caspase-3 staining (right panel, M2).
Flow cytometric analysis of apoptotic and non-apoptotic populations for active caspase-3. Jurkat cells (Human T-cell leukemia; ATCC TIB-152) were left untreated (left panel) or treated for 4 hr with camptothecin (right panel) to induce apoptosis. Cells were permeabilized, fixed, and stained for active caspase-3 as described in the accompanying Staining Protocol. Cells were then analyzed by flow cytometry. Untreated cells were primarily negative for the presence of active caspase-3, whereas greater than one third of the treated cells were positive for active caspase-3 staining (right panel, M2).
本文来自投稿，不代表本人立场，如若转载，请注明出处：http://www.iamyjet.com/kangti/8687.html